There Are a Number of Related Class Action Lawsuits about the Pricing of Hundreds of Brand-Name Prescription Drugs. You may be Included in One or More of the Lawsuits.

To Get Further Information About Your Legal Rights, See the Links Below.

Prescription drug costs are often based on list prices, or benchmarks. The most common pricing benchmark is called the Average Wholesale Price or “AWP.”

Several companies publish the AWP of prescription drugs in printed and electronic databases. Drug manufacturers either provide information used to create AWPs, or report AWPs to the companies that publish AWPs. These lawsuits claim that during the time at issue in the cases, AWPs were unlawfully inflated, increasing the prices of certain drugs. The different lawsuits are listed below.

• The McKesson Proposed Settlement involves claims related to drug price inflation and McKesson Corporation, a drug wholesaler. Consumers and third-party payors (TPPs) may be included in the case. Click here for more information.

• The AWP Track 2 Proposed Settlement involves 11 drug manufacturers and includes refunds to consumers, Medicare recipients, and third-party payors (TPPs). The case involves percentage co-payments for approximately 200 drugs between January 1, 1991 and March 1, 2008. Click here for more information.